Related Experiment Video
Updated: Oct 3, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Does Garlic Supplementation Control Blood Pressure in Patients with Severe Coronary Artery Disease? A Clinical Trial
Marjan Mahdavi-Roshan1, Javad Nasrollahzadeh1, Ali Mohammad Zadeh2
1Department of Guilan Interventional Cardiovascular Research Center, Heshmat Hospital, Guilan University of Medical Sciences, Rasht, IR Iran.
Insights
Garlic powder tablets significantly reduced blood pressure (BP) in patients with severe coronary artery disease (CAD). This natural supplement offers a safe adjunctive treatment for managing hypertension in this high-risk group.
Area of Science:
- Cardiology
- Nutritional Science
- Pharmacology
Background:
- Hypertension is a primary risk factor for cardiovascular diseases, notably coronary artery disease (CAD).
- Effective management of blood pressure (BP) is crucial in mitigating cardiovascular morbidity.
Purpose of the Study:
- To evaluate the efficacy of garlic powder tablets in reducing blood pressure (BP) among patients diagnosed with severe coronary artery disease (CAD).
- To assess the impact of garlic supplementation on blood pressure control in a hypertensive patient cohort with established CAD.
Main Methods:
- A 3-month randomized, placebo-controlled clinical trial involving 56 patients with severe CAD.
- Participants received either 400 mg garlic powder tablets twice daily or a placebo, with BP measurements taken at baseline and study conclusion.
Main Results:
- Garlic supplementation demonstrated a significant reduction in systolic and diastolic blood pressure (BP) compared to placebo in CAD patients.
- The blood pressure-lowering effect of garlic was more pronounced in hypertensive individuals within the study cohort.
- No significant alterations in plasma lipids or lipoproteins were observed in either group; tolerability and compliance were high.
Conclusions:
- Garlic-based treatments show promise as an effective adjunct therapy for controlling blood pressure in patients with coronary artery disease (CAD).
- Garlic supplementation appears to be a safe option for CAD patients, with no reported interactions with other medications.
- Garlic may be considered a valuable, natural addition to the management strategy for hypertension in individuals with severe CAD.
Background:
Hypertension is one of the major risk factors for cardiovascular morbidities, including coronary artery disease (CAD).
Objectives:
With interest on the important role of hypertension in the progression of CAD, this study was designed to estimate the effect of garlic powder tablets on the blood pressure (BP) in patients with severe CAD.
Methods:
A randomized, placebo-controlled, clinical trial was conducted on 56 CAD patients, aged 25 - 75 years old. The patients were randomly divided into two groups: Galois groups (n = 27), receiving garlic powder tablet (400 mg garlic) twice daily and the placebo groups (n = 29), receiving placebo for 3 months. The BP was assessed at baseline and at the end of the study.
Results:
During the 3 months study, in the placebo group, systolic BP (SBP) increased with 6.3 mmHg and diastolic BP (DBP) increased with 4.6 mmHg, changes which were significant. After the 3 months, the effect of garlic on SBP, after adjusting for baseline value, was significant, and this effect was more significant in hypertensive patients. Plasma lipids and lipoproteins did not change significantly in either the garlic or placebo groups, during the study. Tolerability, compliance and acceptability were high in all patients.
Conclusions:
These results demonstrate that treatment with garlic-based drugs can be an effective treatment for controlling BP in CAD patients and has no interaction with other drugs that CAD patients take. Therefore, it may be considered as a safe adjunct treatment for this group of patients.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Coronary Artery Disease IV: Preventive Measures
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
